Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
Technology appraisal guidance
Reference number: TA963
Published:
Evidence
Review and download supporting evidence. Includes the full guideline if available.